Michael York
Keine laufenden Positionen mehr
Vermögen: 59 629 $ am 31.05.2023
Karriereverlauf von Michael York
Ehemalige bekannte Positionen von Michael York
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| METACRINE, INC. | Comptroller/Controller/Auditor | 31.03.2022 | 24.03.2023 |
| Vorstandsvorsitzender | 01.02.2023 | 24.03.2023 | |
| Finanzdirektor/CFO | 31.03.2022 | 24.03.2023 | |
| Corporate Officer/Principal | 01.12.2021 | 31.03.2022 | |
| Präsident | 01.02.2023 | 24.03.2023 | |
| Unternehmenssekretär | 01.02.2023 | 24.03.2023 | |
| Treasurer | 31.03.2022 | 24.03.2023 | |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.06.2018 | 01.11.2021 |
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2015 | 01.06.2018 |
| Sente, Inc. | Vorstandsvorsitzender | 01.07.2013 | 01.12.2014 |
| Präsident | 01.07.2013 | 01.12.2014 | |
| SENTÉ Labs | Vorstandsvorsitzender | - | - |
| Präsident | - | - | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Michael York
| San Diego State University | Undergraduate Degree |
| University of Redlands | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| METACRINE, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
| Sente, Inc. | Technology Services |
| SENTÉ Labs |
- Börse
- Insiders
- Michael York
- Erfahrung
